231 related articles for article (PubMed ID: 18618183)
1. Analysis of clinical applicability of the breast cancer nomogram for positive sentinel lymph node: the canadian experience.
Poirier E; Sideris L; Dubé P; Drolet P; Meterissian SH
Ann Surg Oncol; 2008 Sep; 15(9):2562-7. PubMed ID: 18618183
[TBL] [Abstract][Full Text] [Related]
2. Validation and limitations of use of a breast cancer nomogram predicting the likelihood of non-sentinel node involvement after positive sentinel node biopsy.
Alran S; De Rycke Y; Fourchotte V; Charitansky H; Laki F; Falcou MC; Benamor M; Freneaux P; Salmon RJ; ; Sigal-Zafrani B
Ann Surg Oncol; 2007 Aug; 14(8):2195-201. PubMed ID: 17294071
[TBL] [Abstract][Full Text] [Related]
3. Comparative validation of online nomograms for predicting nonsentinel lymph node status in sentinel lymph node-positive breast cancer.
Hessman CJ; Naik AM; Kearney NM; Jensen AJ; Diggs BS; Troxell ML; Vetto JT
Arch Surg; 2011 Sep; 146(9):1035-40. PubMed ID: 21931000
[TBL] [Abstract][Full Text] [Related]
4. Predicting likelihood of having four or more positive nodes in patient with sentinel lymph node-positive breast cancer: a nomogram validation study.
Unal B; Gur AS; Beriwal S; Tang G; Johnson R; Ahrendt G; Bonaventura M; Soran A
Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):1035-40. PubMed ID: 19327916
[TBL] [Abstract][Full Text] [Related]
5. A model for predicting non-sentinel lymph node metastatic disease when the sentinel lymph node is positive.
Pal A; Provenzano E; Duffy SW; Pinder SE; Purushotham AD
Br J Surg; 2008 Mar; 95(3):302-9. PubMed ID: 17876750
[TBL] [Abstract][Full Text] [Related]
6. The predicted probability of having positive non-sentinel lymph nodes in patients who received neoadjuvant chemotherapy for large operable breast cancer.
Evrensel T; Johnson R; Ahrendt G; Bonaventura M; Falk JS; Keenan D; Soran A
Int J Clin Pract; 2008 Sep; 62(9):1379-82. PubMed ID: 17309608
[TBL] [Abstract][Full Text] [Related]
7. Assessment of the performance of the Stanford Online Calculator for the prediction of nonsentinel lymph node metastasis in sentinel lymph node-positive breast cancer patients.
Scow JS; Degnim AC; Hoskin TL; Reynolds C; Boughey JC
Cancer; 2009 Sep; 115(18):4064-70. PubMed ID: 19517477
[TBL] [Abstract][Full Text] [Related]
8. Predictive probability of four different breast cancer nomograms for nonsentinel axillary lymph node metastasis in positive sentinel node biopsy.
Gur AS; Unal B; Johnson R; Ahrendt G; Bonaventura M; Gordon P; Soran A
J Am Coll Surg; 2009 Feb; 208(2):229-35. PubMed ID: 19228534
[TBL] [Abstract][Full Text] [Related]
9. Predictors of nonsentinel node metastasis in patients with breast cancer after sentinel node metastasis.
Joseph KA; El-Tamer M; Komenaka I; Troxel A; Ditkoff BA; Schnabel F
Arch Surg; 2004 Jun; 139(6):648-51. PubMed ID: 15197092
[TBL] [Abstract][Full Text] [Related]
10. Predicting nonsentinel node status after positive sentinel lymph biopsy for breast cancer: clinicians versus nomogram.
Specht MC; Kattan MW; Gonen M; Fey J; Van Zee KJ
Ann Surg Oncol; 2005 Aug; 12(8):654-9. PubMed ID: 16021535
[TBL] [Abstract][Full Text] [Related]
11. Axillary lymph node dissection in the case of sentinel lymph node micrometastatic invasion: evaluation of three predictive models.
Orsoni M; Clerc J; Golfier F; Cortet M; Raudrant D; Krauth JS
Eur J Obstet Gynecol Reprod Biol; 2011 Oct; 158(2):334-7. PubMed ID: 21669485
[TBL] [Abstract][Full Text] [Related]
12. The MSKCC nomogram for prediction the likelihood of non-sentinel node involvement in a German breast cancer population.
Klar M; Jochmann A; Foeldi M; Stumpf M; Gitsch G; Stickeler E; Watermann D
Breast Cancer Res Treat; 2008 Dec; 112(3):523-31. PubMed ID: 18172758
[TBL] [Abstract][Full Text] [Related]
13. Comparison of two models for the prediction of nonsentinel node metastases in breast cancer.
Ponzone R; Maggiorotto F; Mariani L; Jacomuzzi ME; Magistris A; Mininanni P; Biglia N; Sismondi P
Am J Surg; 2007 Jun; 193(6):686-92. PubMed ID: 17512277
[TBL] [Abstract][Full Text] [Related]
14. Can nomograms predict non-sentinel lymph node metastasis after neoadjuvant chemotherapy in sentinel lymph node-positive breast cancer patients?
Unal B; Gur AS; Ahrendt G; Johnson R; Bonaventura M; Soran A
Clin Breast Cancer; 2009 May; 9(2):92-5. PubMed ID: 19433389
[TBL] [Abstract][Full Text] [Related]
15. Validation of breast cancer nomograms for predicting the non-sentinel lymph node metastases after a positive sentinel lymph node biopsy in a multi-center study.
Gur AS; Unal B; Ozbek U; Ozmen V; Aydogan F; Gokgoz S; Gulluoglu BM; Aksaz E; Ozbas S; Baskan S; Koyuncu A; Soran A;
Eur J Surg Oncol; 2010 Jan; 36(1):30-5. PubMed ID: 19535217
[TBL] [Abstract][Full Text] [Related]
16. Validation of a breast cancer nomogram for predicting nonsentinel node metastases after minimal sentinel node involvement: validation of the Helsinki breast nomogram.
Ouldamer L; Arbion F; Balagny A; Fourquet F; Marret H; Body G
Breast; 2013 Oct; 22(5):787-92. PubMed ID: 23473772
[TBL] [Abstract][Full Text] [Related]
17. The likelihood of additional nodal disease following a positive sentinel lymph node biopsy in breast cancer patients: validation of a nomogram.
Cripe MH; Beran LC; Liang WC; Sickle-Santanello BJ
Am J Surg; 2006 Oct; 192(4):484-7. PubMed ID: 16978955
[TBL] [Abstract][Full Text] [Related]
18. Clinicopathological factors and nomograms predicting nonsentinel lymph node metastases after neoadjuvant chemotherapy in breast cancer patients.
Gimbergues P; Abrial C; Durando X; Le Bouedec G; Cachin F; Penault-Llorca F; Mouret-Reynier MA; Kwiatkowski F; Maublant J; Tchirkov A; Dauplat J
Ann Surg Oncol; 2009 Jul; 16(7):1946-51. PubMed ID: 19408057
[TBL] [Abstract][Full Text] [Related]
19. Validation of a nomogram to predict the risk of nonsentinel lymph node metastases in breast cancer patients with a positive sentinel node biopsy: validation of the MSKCC breast nomogram.
van la Parra RF; Ernst MF; Bevilacqua JL; Mol SJ; Van Zee KJ; Broekman JM; Bosscha K
Ann Surg Oncol; 2009 May; 16(5):1128-35. PubMed ID: 19252954
[TBL] [Abstract][Full Text] [Related]
20. International multicenter tool to predict the risk of nonsentinel node metastases in breast cancer.
Meretoja TJ; Leidenius MH; Heikkilä PS; Boross G; Sejben I; Regitnig P; Luschin-Ebengreuth G; Žgajnar J; Perhavec A; Gazic B; Lázár G; Takács T; Vörös A; Saidan ZA; Nadeem RM; Castellano I; Sapino A; Bianchi S; Vezzosi V; Barranger E; Lousquy R; Arisio R; Foschini MP; Imoto S; Kamma H; Tvedskov TF; Kroman N; Jensen MB; Audisio RA; Cserni G
J Natl Cancer Inst; 2012 Dec; 104(24):1888-96. PubMed ID: 23117131
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
